# A Constraint-Guided Manifold Framework for Quantifying Dosage Noise and Coherence Recovery in Trisomy 21

**Research Concept Proposal**  
**Submitted to: Dr. Mary Ann Allen, Allen Lab, BioFrontiers Institute**  
**University of Colorado Boulder**  
**[Your Full Name]**  
**[Date]**

## Executive Summary

Trisomy 21 is a natural high-noise perturbation on the human genome, resulting from an extra copy of chromosome 21. This causes ~1.5× gene dosage on hundreds of genes, driving transcriptional dysregulation and developmental instability.

We introduce **Residue Manifold Learning (RML)** and the **Constraint-Guided Coherence Score (CGCS)** as a computational framework to quantify dosage noise and coherence recovery. The method encodes genomic segments as residue streams on a discrete modular manifold and measures how well structure is preserved under noise.

A dedicated repository has been created for this collaboration:  
**https://github.com/thinkthoughts/allen-lab-report-tool**

This framework complements the Allen Lab’s expertise in RNA biology, transcriptional propagation, and person-to-person variability in Down syndrome.

## 1. Background

Human development relies on precise gene dosage and bilateral symmetry. Trisomy 21 disrupts this balance, producing both local overexpression and global transcriptional effects. While many changes have been catalogued, integrative metrics that capture **structural coherence** under dosage noise are still needed.

## 2. Residue Manifold Learning (RML) Framework

RML models biological information on a discrete modular manifold using:

- Prime-supported residue lanes (mod-30 or higher)
- Complementary pairing rules mapped as symmetry operations
- **Constraint-Guided Coherence Score (CGCS)**

**Base CGCS formula:**
$$
\text{CGCS} = \text{coverage} \times \text{lane alignment} \times \text{redundancy penalty} \times \text{dead feature penalty} \times \text{reconstruction penalty}
$$

## 3. Application to Trisomy 21

We model chromosome 21 segments as residue streams. The extra copy is treated as increased redundancy and dosage imbalance.

**Adapted CGCS for Trisomy 21:**
$$
\text{CGCS}_{\text{trisomy}} = \text{dosage coverage} \times \text{lane dosage alignment} \times \frac{1}{1 + \text{overexpression imbalance}} \times \frac{1}{1 + \text{global trans-dysregulation}} \times \text{redundancy penalty}
$$

High CGCS corresponds to stable, phase-locked development. Trisomy 21 lowers CGCS, consistent with observed phenotypes.

## 4. Proposed Applications for Allen Lab

1. **Transcriptomic Coherence Scoring** — Apply CGCS to RNA-seq datasets
2. **Person-to-Person Variability Analysis**
3. **Intervention Modeling** — Simulate early therapies and pharmacological candidates (e.g., DYRK1A inhibitors) as projection/recovery operations
4. **Integration with existing pipelines** at BioFrontiers

## 5. Repository & Next Steps

All code, notebooks, and documentation are available at:  
**https://github.com/thinkthoughts/allen-lab-report-tool**

I invite the Allen Lab to explore, fork, or contribute to this repository.

I am available to present the work, run pilot analyses, or adapt the tools based on lab feedback.

## Conclusion

This framework offers a new quantitative lens for understanding and potentially mitigating dosage noise in Trisomy 21 while respecting the underlying physical constraints of the genome.

Thank you for your consideration.

**Contact**  
[Your Email] | [Your Phone]  
GitHub: thinkthoughts (allen-lab-report-tool + residue-manifold-learning)  
Additional materials: labreports.app
